Which has higher earnings & valuation, SDGR or WAY?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.97 -$103.26M -$0.74 N/A Waystar $1.10B 4.55 $112.09M $0.70 37.26

Is SDGR or WAY more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Waystar 11.18% 7.03% 4.75%

Does the media refer more to SDGR or WAY?

In the previous week, Waystar had 5 more articles in the media than Schrodinger. MarketBeat recorded 13 mentions for Waystar and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 1.23 beat Waystar's score of 0.87 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, SDGR or DOCS?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.97 -$103.26M -$0.74 N/A Doximity $655.57M 7.34 $196.05M $0.85 31.78

Is SDGR or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Doximity 25.48% 18.06% 15.40%

Does the media favor SDGR or DOCS?

In the previous week, Schrodinger and Schrodinger both had 8 articles in the media. Schrodinger's average media sentiment score of 1.23 beat Doximity's score of 0.58 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, HTFL or SDGR?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 24.55 -$116.79M -$1.83 N/A Schrodinger $255.87M 5.97 -$103.26M -$0.74 N/A

Is HTFL or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Schrodinger -20.98% -16.37% -8.19%

Does the media favor HTFL or SDGR?

In the previous week, Heartflow had 3 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Heartflow and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 1.23 beat Heartflow's score of 1.18 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, CERT or SDGR?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.96 -$1.60M -$0.45 N/A Schrodinger $255.87M 5.97 -$103.26M -$0.74 N/A

Is CERT or SDGR more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer CERT or SDGR?

In the previous week, Schrodinger had 4 more articles in the media than Certara. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for Certara. Certara's average media sentiment score of 1.50 beat Schrodinger's score of 1.23 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, GDRX or SDGR?

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.52 $30.44M $0.04 88.25 Schrodinger $255.87M 5.97 -$103.26M -$0.74 N/A

Is GDRX or SDGR more profitable?

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer GDRX or SDGR?

In the previous week, Schrodinger had 4 more articles in the media than GoodRx. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for GoodRx. Schrodinger's average media sentiment score of 1.23 beat GoodRx's score of 0.73 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Schrodinger (SDGR) Competitors

$20.71 -0.17 (-0.81%)

As of 09/3/2026 04:00 PM Eastern

Compare

SDGR vs. WAY, DOCS, HTFL, CERT, and GDRX

Should you buy Schrodinger stock or one of its competitors? Schrodinger's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Heartflow (HTFL), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Schrodinger compare to Waystar?

Schrodinger (NASDAQ:SDGR) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.97	-$103.26M	-$0.74	N/A
Waystar	$1.10B	4.55	$112.09M	$0.70	37.26

Schrodinger has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market.

79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Waystar	11.18%	7.03%	4.75%

In the previous week, Waystar had 5 more articles in the media than Schrodinger. MarketBeat recorded 13 mentions for Waystar and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 1.23 beat Waystar's score of 0.87 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger presently has a consensus price target of $20.50, suggesting a potential downside of 1.01%. Waystar has a consensus price target of $35.52, suggesting a potential upside of 36.20%. Given Waystar's stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Waystar	1 Sell rating(s)	2 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Summary

Waystar beats Schrodinger on 12 of the 17 factors compared between the two stocks.

How does Schrodinger compare to Doximity?

Schrodinger (NASDAQ:SDGR) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Doximity	25.48%	18.06%	15.40%

Schrodinger has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market. Comparatively, Doximity has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market.

In the previous week, Schrodinger and Schrodinger both had 8 articles in the media. Schrodinger's average media sentiment score of 1.23 beat Doximity's score of 0.58 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.97	-$103.26M	-$0.74	N/A
Doximity	$655.57M	7.34	$196.05M	$0.85	31.78

Schrodinger currently has a consensus target price of $20.50, indicating a potential downside of 1.01%. Doximity has a consensus target price of $32.43, indicating a potential upside of 20.06%. Given Doximity's higher possible upside, analysts clearly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28

Summary

Doximity beats Schrodinger on 13 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Heartflow currently has a consensus price target of $43.43, indicating a potential downside of 12.64%. Schrodinger has a consensus price target of $20.50, indicating a potential downside of 1.01%. Given Schrodinger's higher possible upside, analysts plainly believe Schrodinger is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	24.55	-$116.79M	-$1.83	N/A
Schrodinger	$255.87M	5.97	-$103.26M	-$0.74	N/A

79.1% of Schrodinger shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Schrodinger	-20.98%	-16.37%	-8.19%

In the previous week, Heartflow had 3 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Heartflow and 8 mentions for Schrodinger. Schrodinger's average media sentiment score of 1.23 beat Heartflow's score of 1.18 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Schrodinger beats Heartflow on 10 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Certara?

Certara (NASDAQ:CERT) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Schrodinger	-20.98%	-16.37%	-8.19%

In the previous week, Schrodinger had 4 more articles in the media than Certara. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for Certara. Certara's average media sentiment score of 1.50 beat Schrodinger's score of 1.23 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara presently has a consensus target price of $8.28, indicating a potential upside of 1.82%. Schrodinger has a consensus target price of $20.50, indicating a potential downside of 1.01%. Given Certara's stronger consensus rating and higher probable upside, equities research analysts clearly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Certara has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.96	-$1.60M	-$0.45	N/A
Schrodinger	$255.87M	5.97	-$103.26M	-$0.74	N/A

74.0% of Certara shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Certara beats Schrodinger on 12 of the 17 factors compared between the two stocks.

How does Schrodinger compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

GoodRx has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.52	$30.44M	$0.04	88.25
Schrodinger	$255.87M	5.97	-$103.26M	-$0.74	N/A

GoodRx has a beta of 1.59, indicating that its share price is 59% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Schrodinger had 4 more articles in the media than GoodRx. MarketBeat recorded 8 mentions for Schrodinger and 4 mentions for GoodRx. Schrodinger's average media sentiment score of 1.23 beat GoodRx's score of 0.73 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx currently has a consensus price target of $4.23, indicating a potential upside of 19.75%. Schrodinger has a consensus price target of $20.50, indicating a potential downside of 1.01%. Given GoodRx's higher probable upside, equities research analysts plainly believe GoodRx is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

GoodRx has a net margin of 2.07% compared to Schrodinger's net margin of -20.98%. GoodRx's return on equity of 7.22% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Schrodinger	-20.98%	-16.37%	-8.19%

Summary

GoodRx beats Schrodinger on 9 of the 16 factors compared between the two stocks.

Get Schrodinger News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SDGR vs. The Competition

Export

Metric	Schrodinger	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.54B	$1.76B	$7.26B	$12.73B
Dividend Yield	N/A	4.70%	2.53%	8.86%
P/E Ratio	-27.99	21.24	273.29	25.38
Price / Sales	5.97	83.99	613.45	92.55
Price / Cash	N/A	31.87	77.82	52.26
Price / Book	4.64	7.35	12.89	6.14
Net Income	-$103.26M	-$26.60M	$3.47B	$349.01M
7 Day Performance	5.13%	-0.13%	0.60%	-0.27%
1 Month Performance	32.33%	10.97%	5.73%	0.68%
1 Year Performance	9.17%	-15.06%	25.35%	14.84%

Schrodinger Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SDGR Schrodinger	1.1533 of 5 stars	$20.71 -0.8%	$20.50 -1.0%	+7.4%	$1.54B	$255.87M	N/A	790	Positive News
WAY Waystar	4.5684 of 5 stars	$25.35 +1.4%	$35.00 +38.1%	-30.4%	$4.80B	$1.10B	36.21	1,700	Insider Trade
DOCS Doximity	4.641 of 5 stars	$25.25 -0.3%	$32.43 +28.4%	N/A	$4.51B	$644.86M	29.71	890
HTFL Heartflow	2.1832 of 5 stars	$50.20 +0.9%	$43.43 -13.5%	+58.9%	$4.33B	$212.07M	N/A	699	Positive News
CERT Certara	1.8322 of 5 stars	$7.96 -5.6%	$8.28 +4.0%	-22.6%	$1.29B	$418.84M	N/A	1,576	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SDGR) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Schrodinger (SDGR) Competitors